Andrew James King is Chief Scientific Officer of CHINOOK THERAPEUTICS, INC.. Currently has a direct ownership of 0 shares of KDNY, which is worth approximately $0. The most recent transaction as insider was on Aug 11, 2023, when has been sold 19,157 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Andrew James King Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 11 2023
SELL
Sale (or disposition) back to the issuer
-
19,157 Reduced 100.0%
0 Common Stock
Aug 01 2023
SELL
Open market or private sale
$45,587 $39.03 p/Share
1,168 Reduced 5.75%
19,157 Common Stock
Jul 29 2023
BUY
Exercise of conversion of derivative security
-
3,333 Added 14.09%
20,325 Common Stock
Apr 03 2023
SELL
Open market or private sale
$116,700 $23.34 p/Share
5,000 Reduced 22.74%
16,992 Common Stock
Apr 03 2023
BUY
Exercise of conversion of derivative security
$875 $0.35 p/Share
2,500 Added 10.21%
21,992 Common Stock
Feb 10 2023
SELL
Open market or private sale
$56,810 $23.75 p/Share
2,392 Reduced 10.93%
19,492 Common Stock
Feb 10 2023
BUY
Exercise of conversion of derivative security
-
6,803 Added 23.71%
21,884 Common Stock
Jan 31 2023
SELL
Open market or private sale
$80,061 $24.68 p/Share
3,244 Reduced 17.7%
15,081 Common Stock
Jan 31 2023
BUY
Exercise of conversion of derivative security
-
8,333 Added 31.26%
18,325 Common Stock
Jan 03 2023
SELL
Open market or private sale
$258,200 $25.82 p/Share
10,000 Reduced 50.02%
9,992 Common Stock
Jan 03 2023
BUY
Exercise of conversion of derivative security
$2,625 $0.35 p/Share
7,500 Added 27.28%
19,992 Common Stock
Oct 06 2022
SELL
Open market or private sale
$70,037 $19.69 p/Share
3,557 Reduced 22.16%
12,492 Common Stock
Oct 06 2022
BUY
Exercise of conversion of derivative security
-
10,152 Added 38.75%
16,049 Common Stock
Aug 04 2022
SELL
Open market or private sale
$100,000 $20.0 p/Share
5,000 Reduced 45.88%
5,897 Common Stock
Aug 04 2022
BUY
Exercise of conversion of derivative security
$1,750 $0.35 p/Share
5,000 Added 31.45%
10,897 Common Stock
Jul 11 2022
SELL
Open market or private sale
$90,450 $18.09 p/Share
5,000 Reduced 45.88%
5,897 Common Stock
Jul 11 2022
BUY
Exercise of conversion of derivative security
$1,750 $0.35 p/Share
5,000 Added 31.45%
10,897 Common Stock
Apr 11 2022
SELL
Open market or private sale
$76,800 $15.36 p/Share
5,000 Reduced 45.88%
5,897 Common Stock
Apr 11 2022
BUY
Exercise of conversion of derivative security
$1,750 $0.35 p/Share
5,000 Added 31.45%
10,897 Common Stock
Feb 18 2022
SELL
Open market or private sale
$32,500 $13.0 p/Share
2,500 Reduced 29.77%
5,897 Common Stock
Feb 11 2022
SELL
Open market or private sale
$31,825 $12.74 p/Share
2,498 Reduced 22.93%
8,397 Common Stock
Feb 10 2022
SELL
Open market or private sale
$33,275 $13.31 p/Share
2,500 Reduced 37.91%
4,094 Common Stock
Feb 10 2022
BUY
Exercise of conversion of derivative security
-
6,801 Added 38.43%
10,895 Common Stock
Feb 10 2022
BUY
Exercise of conversion of derivative security
$875 $0.35 p/Share
2,500 Added 27.49%
6,594 Common Stock
Nov 09 2021
SELL
Open market or private sale
$67,650 $13.53 p/Share
5,000 Reduced 54.98%
4,094 Common Stock
AJK

Andrew James King

Chief Scientific Officer
Seattle, WA

Track Institutional and Insider Activities on KDNY

Follow CHINOOK THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KDNY shares.

Notify only if

Insider Trading

Get notified when an Chinook Therapeutics, Inc. insider buys or sells KDNY shares.

Notify only if

News

Receive news related to CHINOOK THERAPEUTICS, INC.

Track Activities on KDNY